Takeda Pharmaceutical Company (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Takeda Pharmaceutical Company" in English language version.

refsWebsite

Global rank English rank

9takeda.com

low place

8biospace.com

low place

7,595^th place

6genengnews.com

low place

6,625^th place

5reuters.com

49^th place

47^th place

5web.archive.org

1^st place

4nikkei.com

211^th place

915^th place

3bloomberg.com

99^th place

77^th place

3nytimes.com

7^th place

2chicagobusiness.com

4,398^th place

2,433^rd place

2chicagotribune.com

95^th place

70^th place

1greatplacetowork.com

low place

1cnn.com

28^th place

26^th place

1bloomberglaw.com

5,670^th place

3,086^th place

1latimes.com

22^nd place

19^th place

1marketwatch.com

1,303^rd place

808^th place

1bioworld.com

low place

1abril.com.br

508^th place

1,866^th place

1pharmaceutical-technology.com

low place

1telegraph.co.uk

30^th place

24^th place

1drugs.com

399^th place

333^rd place

1fiercepharma.com

low place

8,921^st place

1mit.edu

415^th place

327^th place

1aitimes.media

low place

1healthcareitnews.com

low place

1bostonglobe.com

553^rd place

334^th place

1fiercebiotech.com

low place

8,828^th place

1justice.gov

918^th place

556^th place

1wsj.com

79^th place

65^th place

1worldcat.org

5^th place

1endpts.com

low place

1financialpost.com

3,491^st place

1,999^th place

1ibtimes.com

911^th place

628^th place

1hrc.org

5,694^th place

3,445^th place

abril.com.br

exame.abril.com.br

Hirschler, Ben (2012-05-25). "Farmacêutica Takeda comprará Multilab por até R$ 540 mi". Grupo Abril (in Portuguese). Exame. Retrieved 2013-01-27.

aitimes.media

analytica, TOKYO (2020-01-07). "武田薬品とMITがAI研究を推進するプログラムを発表 | 医療とAIのニュース・最新記事 - The Medical AI Times". The AI Times (in Japanese). Retrieved 2020-11-13.

biospace.com

bioworld.com

"Alnylam Signs Potential $1B RNAi Agreement with Takeda". bioworld.com. Retrieved 2020-02-20.

bloomberg.com

Du, Lisa (2018-12-12). "Daring Deal by French CEO Sets Japan's Takeda on Global Path". Bloomberg.com. Archived from the original on 2021-01-22. Retrieved 2020-02-20.
Du, Lisa; Takahashi, Maiko (8 May 2018). "Takeda Clinches $62 Billion Deal to Buy Drugmaker Shire". Bloomberg. Retrieved 6 July 2019.
Feeley, Jef; Matsuyama, Kanoko (9 April 2014). "Takeda, Lilly Jury Awards $9 Billion Over Actos Risks". bloomberg.com.

bloomberglaw.com

news.bloomberglaw.com

"Immediate Actos Appeal Will Resolve Uncertainty, Takeda Says". news.bloomberglaw.com. Retrieved 2020-02-20.

bostonglobe.com

Saltzmam, Jonathan (May 24, 2024). "Drug giant Takeda plans more than 640 layoffs in Massachusetts". BostonGlobe.com. Retrieved 2024-05-25.

chicagobusiness.com

"Takeda shrinks its Deerfield workforce, as it adds in Boston". Crain's Chicago Business. 2017-07-18. Retrieved 2020-02-20.
"Abbott, Takeda to end joint venture". Crain's Chicago Business. 2008-03-19. Retrieved 2020-02-20.

chicagotribune.com

Japson, Bruce (Apr 29, 2001). "The Lupron loophole: Cancer drug strikes it rich". Chicago tribune. Retrieved 19 June 2021.

archives.chicagotribune.com

Marrazzo, Amanda (2008-05-15). "Featured Articles From The Chicago Tribune". Archives.chicagotribune.com. Retrieved 2010-09-18.

cnn.com

money.cnn.com

"100 Best Companies to Work For 2012". Fortune. 2012-02-06. Retrieved 2018-03-29.

drugs.com

"Ninlaro (ixazomib) FDA Approval History". Drugs.com. Retrieved 2020-02-20.

endpts.com

"Takeda continues post-Shire selloff, inching closer to $10B goal". Endpoints News. Retrieved 2020-06-12.

fiercebiotech.com

"Takeda Pharmaceutical to Pay Abbott Laboratories up to $1.5B in Venture Split". FierceBiotech. 20 March 2008. Retrieved 2020-02-20.

fiercepharma.com

"Takeda wraps 30 emerging markets drugs in $200M selloff to Swiss pharma Acino". FiercePharma. 15 October 2019. Retrieved 2019-10-15.

financialpost.com

business.financialpost.com

"Takeda to Divest OTC and Select Non-core Assets in Asia Pacific to Celltrion for up to $278 Million USD | Financial Post". Financialpost. 2020-06-11. Retrieved 2020-06-12.

genengnews.com

"Takeda, BioMotiv Launch $25M Drug Development Partnership". Genetic Engineering & Biotechnology News. Mary Ann Liebert, Inc. 2014-09-26. Retrieved 2015-04-23.
"Takeda, MacroGenics Launch Up to $1.6B Expansion of DART Collaboration". Genetic Engineering & Biotechnology News. Mary Ann Liebert, Inc. 2014-09-30. Retrieved 2015-04-23.
"Takeda Spins Out Research Team into Neuroscience Startup". 2016-12-02.
"Takeda to Acquire ARIAD Pharmaceuticals for $5.2B". 2017-01-09.
"Takeda to Acquire TiGenix for €520M". 2018-01-05.
Philippidis, Alex (1 July 2019). "Top 10 M&A Deasl of January—June 2019". Genetic Engineering & Biotechnology News. And it didn't include earlier-announced deals completed in 2019, such as Takeda Pharmaceutical's £46 billion ($58.6 billion) purchase of Shire.

greatplacetowork.com

"Working at Takeda Pharmaceuticals NA".

healthcareitnews.com

"MIT, Takeda collaborate on new healthcare AI applications". Healthcare IT News. 2020-01-06. Retrieved 2020-11-13.

hrc.org

"Corporate Partners". Human Rights Campaign. Archived from the original on 2022-07-14. Retrieved 2022-07-14.

ibtimes.com

"Japan's Takeda Agrees To $2.4B Settlement In Diabetes Drug Actos Lawsuit Over Cancer Risk Allegations". International Business Times. 29 April 2015.

justice.gov

"Press Release: TAP Pharmaceutical Products Inc. and Seven Others Charged with Health Care Crimes". US Department of Justice. Oct 3, 2001. Retrieved June 19, 2021.

latimes.com

"Japan's Takeda to Acquire Syrrx". Los Angeles Times. 2005-02-08. Archived from the original on 2020-02-20. Retrieved 2020-02-20.

marketwatch.com

"Takeda, Amgen in exclusive tie-up for Japanese market". MarketWatch. 2008-02-04. Retrieved 2010-09-18.

mit.edu

news.mit.edu

"MIT School of Engineering and Takeda join to advance research in artificial intelligence and health". MIT News | Massachusetts Institute of Technology. 6 January 2020. Retrieved 2020-11-13.

nikkei.com

asia.nikkei.com

"Takeda offers early retirement to workers as young as 30". Nikkei Asia.
"Novartis to buy Takeda's eyedrop unit for $5.3bn". Nikkei Asian Review. Retrieved 2020-06-12.
"Takeda sells Russian assets in $660m deal to cut Shire debt". Nikkei Asian Review. Retrieved 2020-06-12.
"Takeda sells 18 drugs to South Korea's Celltrion in $278m deal". Nikkei Asian Review. Retrieved 2020-06-12.

nytimes.com

Petersen, Melody (Oct 4, 2001). "2 Drug Makers to Pay $875 Million to Settle Fraud Case". The New York Times. Retrieved June 19, 2021.
"Takeda Agrees to Pay $2.4 Billion to Settle Suits Over Cancer Risk of Actos". The New York Times. 29 April 2015.

dealbook.nytimes.com

Dealbook (2011-05-19). "Takeda to Buy Nycomed for $13.7 Billion". DealBook. Retrieved 2020-02-20.

pharmaceutical-technology.com

"Takeda to acquire URL Pharma for $800m". 11 April 2012. Archived from the original on 2020-02-20. Retrieved 2020-02-20.

reuters.com

Chris Gallagher (2015-03-15). Muralikumar Anantharaman (ed.). "Japan drugmaker Takeda says Christophe Weber to become CEO April 1". Reuters. Retrieved 2015-04-20.
"Takeda to buy Millennium Pharma for $8.8 billion". Reuters. 2008-04-10. Retrieved 2020-02-20.
"Takeda sells Mideast, Africa drug portfolio to Switzerland's Acino". Reuters. 2019-10-15. Retrieved 2019-10-15.
Roy, Sriparna (February 12, 2024). "Takeda's treatment becomes first oral therapy for esophageal condition in US". Reuters. Retrieved February 12, 2024.
"BRIEF-Takeda Pharmaceutical Enters Into Agreement To Divest Portfolio Of Select Non-Core OTC And Prescription Pharmaceutical Products". Reuters. 2020-06-11. Retrieved 2020-06-12.

takeda.com

"Company Facts | Takeda". www.takeda.com.
"The History of Takeda – 1781 to 1944 | Takeda".
"Share Data | Takeda".
"Financial Results for Fiscal 2012" (PDF). Takeda Pharmaceutical Company Limited. 2013-05-09. Retrieved 2013-06-13.
"FAQ." Takeda Pharmaceutical Company. Retrieved on 2011-02-02. "Q : Where is Takeda located? A : The Head Office is located in Osaka, Japan, and the Tokyo Head Office is located in Tokyo, Japan."
"Overview." Takeda Pharmaceutical Company. Retrieved on 2011-02-02. "Headquarters Head Office 1-1, Doshomachi 4-chome, Chuo-ku, Osaka 540-8645" and "Tokyo Head Office 12-10, Nihonbashi 2-chome, Chuo-ku, Tokyo 103-8668"
"Christophe Weber". Takeda. Archived from the original on 2024-04-15. Retrieved 2024-04-15.
"Takeda to Divest TachoSil® to Corza Health for €350 Million". www.takeda.com. Retrieved 2023-04-09.

assets-dam.takeda.com

"Financial Results for Fiscal 2023" (PDF). Takeda Pharmaceutical Company Limited. May 11, 2023. Retrieved December 27, 2023.

telegraph.co.uk

Julia Bradshaw for The Daily Telegraph, 16 December 2015. AstraZeneca to buy Takeda's lung business for £383m.Accessed: 17 December 2015.

web.archive.org

"Christophe Weber". Takeda. Archived from the original on 2024-04-15. Retrieved 2024-04-15.
Du, Lisa (2018-12-12). "Daring Deal by French CEO Sets Japan's Takeda on Global Path". Bloomberg.com. Archived from the original on 2021-01-22. Retrieved 2020-02-20.
"Japan's Takeda to Acquire Syrrx". Los Angeles Times. 2005-02-08. Archived from the original on 2020-02-20. Retrieved 2020-02-20.
"Takeda to acquire URL Pharma for $800m". 11 April 2012. Archived from the original on 2020-02-20. Retrieved 2020-02-20.
"Corporate Partners". Human Rights Campaign. Archived from the original on 2022-07-14. Retrieved 2022-07-14.

worldcat.org

search.worldcat.org

Wang, Shirley S. (2008-03-20). "Abbott, Takeda to End Joint Venture". Wall Street Journal. ISSN 0099-9660. Retrieved 2020-02-20.

wsj.com

Wang, Shirley S. (2008-03-20). "Abbott, Takeda to End Joint Venture". Wall Street Journal. ISSN 0099-9660. Retrieved 2020-02-20.